Sorrento Therapeutics Inc (NASDAQ:SRNE)

11.39
Delayed Data
As of Apr 01
 -0.17 / -1.47%
Today’s Change
3.10
Today|||52-Week Range
14.30
+13.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues682.6K529.2K583.8K460.1K
 
 
 
 
 
Cost of Goods Sold0.002.4M--4.4K
 
 
 
Depreciation And Amortization23.4K159.2K293.3K1.3M
 
 
 
 
 
 
Operating ExpensesGross Income659.2K-2.0M---834.7K
 
 
 
 
General Expenses2.5M1.2M5.1M14.8M
 
 
 
 
 
Research And Development1.4M--3.8M9.0M
 
 
 
 
Total Operating Expenses2.5M3.8M5.4M16.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M-3.2M-4.9M-15.7M
 
 
 
 
 
Extraordinary Charge0.000.000.00-6.0M
 
 
Interest Expense On Debt0.000.000.00253.2K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-3.2M-4.8M-21.9M
 
 
 
 
 
Net Income-1.8M-3.2M-4.8M-21.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.8M9.9M11.4M15.0M
 
 
 
 
 
Shares To Calculate EPS Diluted8.8M9.9M11.4M15.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.25-$0.50-$1.46
 
 
 
 
 
EPS Diluted-$0.25-$0.25-$0.50-$1.46
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account